NasdaqGM - Delayed Quote • USD
Alimera Sciences, Inc. (ALIM)
At close: April 25 at 4:00 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 3 | 3 | 3 | 2 |
Avg. Estimate | -0.06 | -0.01 | -0.01 | 0.2 |
Low Estimate | -0.07 | -0.02 | -0.04 | 0.1 |
High Estimate | -0.04 | 0 | 0.03 | 0.31 |
Year Ago EPS | -0.71 | -1.32 | -0.79 | -0.01 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 4 | 4 | 4 | 3 |
Avg. Estimate | 22.25M | 25.18M | 103.79M | 118.79M |
Low Estimate | 21M | 24.46M | 100M | 112.24M |
High Estimate | 23.72M | 25.76M | 105.88M | 127.02M |
Year Ago Sales | 13.55M | 17.54M | 80.75M | 103.79M |
Sales Growth (year/est) | 64.30% | 43.60% | 28.50% | 14.50% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -0.32 | 0.01 | -0.06 | 0 |
EPS Actual | -0.71 | -1.32 | -0.06 | -0.07 |
Difference | -0.39 | -1.33 | 0 | -0.07 |
Surprise % | -121.90% | -13,300.00% | 0.00% | -- |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.06 | -0.01 | -0.01 | 0.2 |
7 Days Ago | -0.07 | -0.03 | -0.05 | 0.13 |
30 Days Ago | -0.07 | -0.03 | -0.07 | -0.05 |
60 Days Ago | -0.02 | 0 | 0.07 | 0.14 |
90 Days Ago | -0.02 | 0 | 0.07 | 0.14 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 1 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | ALIM | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 91.50% | -- | -- | 2.60% |
Next Qtr. | 99.20% | -- | -- | 13.40% |
Current Year | 98.70% | -- | -- | 5.20% |
Next Year | 2,100.00% | -- | -- | 13.30% |
Next 5 Years (per annum) | -- | -- | -- | 11.11% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Initiated | Maxim Group: Buy | 3/25/2024 |
Maintains | HC Wainwright & Co.: Buy to Buy | 3/8/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 8/14/2023 |
Upgrade | Alliance Global Partners: Neutral to Buy | 6/12/2023 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 5/25/2023 |
Maintains | HC Wainwright & Co.: Buy to Buy | 5/19/2023 |
Related Tickers
CPIX Cumberland Pharmaceuticals Inc.
1.7000
+5.59%
39L.DU PetIQ Inc
15.00
0.00%
1CE0.F Vitura Health Limited
0.0630
+10.53%
MBGPF Moberg Pharma AB (publ)
3.4500
+6.15%
GRNF GRN Holding Corporation
0.0710
0.00%
EVOK Evoke Pharma, Inc.
0.4360
-2.57%
HROW Harrow, Inc.
10.00
-2.63%
SBBCF Simply Better Brands Corp.
0.2668
0.00%
CLVRW Clever Leaves Holdings Inc.
0.0349
-12.75%
BFRIW Biofrontera Inc.
0.0600
+20.24%